Cargando…
Role of Ceramidases in Sphingolipid Metabolism and Human Diseases
Human pathologies such as Alzheimer’s disease, type 2 diabetes-induced insulin resistance, cancer, and cardiovascular diseases have altered lipid homeostasis. Among these imbalanced lipids, the bioactive sphingolipids ceramide and sphingosine-1 phosphate (S1P) are pivotal in the pathophysiology of t...
Autores principales: | Parveen, Farzana, Bender, Daniel, Law, Shi-Hui, Mishra, Vineet Kumar, Chen, Chih-Chieh, Ke, Liang-Yin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6952831/ https://www.ncbi.nlm.nih.gov/pubmed/31817238 http://dx.doi.org/10.3390/cells8121573 |
Ejemplares similares
-
Gene cloning of a neutral ceramidase from the sphingolipid metabolic pathway based on transcriptome analysis of Amorphophallus muelleri
por: Zhong, Lin, et al.
Publicado: (2018) -
Acid Ceramidase Protects Against Hepatic Ischemia/Reperfusion Injury by Modulating Sphingolipid Metabolism and Reducing Inflammation and Oxidative Stress
por: Jiang, Yuan, et al.
Publicado: (2021) -
Molecular and Cellular Mechanisms of Electronegative Lipoproteins in Cardiovascular Diseases
por: Ke, Liang-Yin, et al.
Publicado: (2020) -
Alkaline Ceramidase 3 Deficiency Results in Purkinje Cell Degeneration and Cerebellar Ataxia Due to Dyshomeostasis of Sphingolipids in the Brain
por: Wang, Kai, et al.
Publicado: (2015) -
An Updated Review of Lysophosphatidylcholine Metabolism in Human Diseases
por: Law, Shi-Hui, et al.
Publicado: (2019)